In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 69 for your search:
Drug:  pentostatin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8862

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8582, SWOG-8694, CALGB-8582

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8691, CAN-NCIC-HL1, CLB-8791, EST-2487, INT-0073, HL1

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 03017, NIP-03-007, NCT00254163

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 months to 21 years
Sponsor: Other
Protocol IDs: MUDSIB, NCT01188798

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000068349, UCLA-0001032, SUPERGEN-UCLA-000103201, NCI-G00-1879, NCT00006968

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-82-C-150, NCI-NMOB-827

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: EST-1488

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor:
Protocol IDs: MSKCC-93013, NCI-V93-0268

10.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: ID00-132, NCT00506922

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 05-077, MSKCC-05077, NCT00546377

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-98083, NCI-G98-1482, NCT00003658

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PHARMATECH-N007, PHARMATECH-20001631, SUPERGEN-PHARMATECH-N007, NCT00026351

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1483

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8220

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8303

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 to 76
Sponsor: NCI
Protocol IDs: EST-1480

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: OSU-IOU-8111, NCI-W81-0945, W81-0945

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-IOU-8405, NCI-T83-1285D, T83-1285

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-IOU-8311, NCI-T83-0892W, T83-0892

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND22, NCI-T85-0020R, T85-0020, IND22

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: CLB-8511, CALGB-8511

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-85HO037, OSU-IOU-8517, NCI-T85-0039D, T85-0039

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND24, NCI-T85-0179W, T85-0179, IND24

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8555, CALGB-8555
1    
New Search